Interestingly, we found that RAN acetylation was significantly decreased in CRC cells after RSL1D1 knockdown, while the acetylation levels of RAN were greatly increased in CRC cells overexpressing RSL1D1 (Fig. S4G). The gene discussed is RAN; the disease is colorectal carcinoma.